Overige Sorteren Publicatiedatum oplopendPublicatiedatum aflopend Filteren EHA 2019 - Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities Stephan Grupp, MD, PhD, werkzaam in het Children’s Hospital of Philadelphia, Philadelphia, USA Lees meer 0719HEM1203998HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Tisagenlecleucel (Kymriah) Prof. Dominik Wolf, MD, werkzaam in de Medical University Innsbruck, Innsbruck, AustriaLees meer 0719HEM1203998HematologieHematologieALLAndere categorieënEHA 2019Other Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Targeting senescence against cancer and aging Dr. Peter de Keizer werkzaam in het UMCU Targeting senescence against cancer and aging Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Combination therapies in frontline and relapse Prof. dr. Arnon Kater werkzaam in het Amsterdam UMC Combination therapies in frontline and relapse Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Presidential symposium Prof. dr. Pieter Sonneveld werkzaam in het Erasmus MC Presidential symposium Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - New whole genome association scanning approach for the discovery of HLA class I-restricted minor histocompatibility antigens Drs. Kyra Fuchs werkzaam in het LUMC New whole genome association scanning approach for the discovery of HLA class I-restricted minor histocompatibility antigens ...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Reduced intensity conditioning regimen with alemtuzumab based T-cell depletion enables early post-transplantation cellular intervention restoring graft versus leukemia effects in older AML patients Drs. Eva Koster werkzaam in het LUMC Reduced intensity conditioning regimen with alemtuzumab based T-cell depletion enables early post-transplantation cellular intervention...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Distinct and common deregulated pathways in RUNX1, GATA1 and GFI1B associated bleeding disorders Drs. Maaike van Bergen werkzaam in het Radboudumc Distinct and common deregulated pathways in RUNX1, GATA1 and GFI1B associated bleeding disorders...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Successful treatment of intestinal graft-versus-host disease with fecal microbiota transplantation Drs. Yannouck van Lier werkzaam in het Amsterdam UMC Successful treatment of intestinal graft-versus-host disease with fecal microbiota...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken EHA 2019 - Red blood cell generation from human induced pluripotent stem cells Drs. Emile van den Akker werkzaam in het Sanquin, Amsterdam Red blood cell generation from human induced pluripotent stem cells ...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken Toon meer
EHA 2019 - Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities Stephan Grupp, MD, PhD, werkzaam in het Children’s Hospital of Philadelphia, Philadelphia, USA Lees meer 0719HEM1203998HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Tisagenlecleucel (Kymriah) Prof. Dominik Wolf, MD, werkzaam in de Medical University Innsbruck, Innsbruck, AustriaLees meer 0719HEM1203998HematologieHematologieALLAndere categorieënEHA 2019Other Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Targeting senescence against cancer and aging Dr. Peter de Keizer werkzaam in het UMCU Targeting senescence against cancer and aging Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Combination therapies in frontline and relapse Prof. dr. Arnon Kater werkzaam in het Amsterdam UMC Combination therapies in frontline and relapse Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Presidential symposium Prof. dr. Pieter Sonneveld werkzaam in het Erasmus MC Presidential symposium Lees meer 0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - New whole genome association scanning approach for the discovery of HLA class I-restricted minor histocompatibility antigens Drs. Kyra Fuchs werkzaam in het LUMC New whole genome association scanning approach for the discovery of HLA class I-restricted minor histocompatibility antigens ...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Reduced intensity conditioning regimen with alemtuzumab based T-cell depletion enables early post-transplantation cellular intervention restoring graft versus leukemia effects in older AML patients Drs. Eva Koster werkzaam in het LUMC Reduced intensity conditioning regimen with alemtuzumab based T-cell depletion enables early post-transplantation cellular intervention...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Distinct and common deregulated pathways in RUNX1, GATA1 and GFI1B associated bleeding disorders Drs. Maaike van Bergen werkzaam in het Radboudumc Distinct and common deregulated pathways in RUNX1, GATA1 and GFI1B associated bleeding disorders...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Successful treatment of intestinal graft-versus-host disease with fecal microbiota transplantation Drs. Yannouck van Lier werkzaam in het Amsterdam UMC Successful treatment of intestinal graft-versus-host disease with fecal microbiota...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
EHA 2019 - Red blood cell generation from human induced pluripotent stem cells Drs. Emile van den Akker werkzaam in het Sanquin, Amsterdam Red blood cell generation from human induced pluripotent stem cells ...Lees meer0719HEM1194550HematologieHematologieEHA 2019Andere categorieënOther Delen Twitter Linkedin Facebook Pinterest Google plus Afdrukken
